LipoScience CEO and leadership

Mr. Richard O. Brajer is a Chief Executive Officer, UBS 21st Annual Healthcare Services Conference, Chief Executive Officer at LIPOSCIENCE INC and is based in United States.

James D Otvos is an Exec VP/Chief Scientific Ofcr at LIPOSCIENCE INC. He has worked as Board Member at LIPOSCIENCE INC, Exec VP/Chief Scientific Ofcr at Lipomed AG, and Professor at North Carolina State University. James studied at University of California - UC Berkeley and Yale University.

Lucy has over 30 years of experience in pharmaceutical and medical technology management for both private and public healthcare companies. She most recently served as Executive Vice President and Chief Financial Officer for LipoScience, Inc. a medical device company. At Liposcience, she was a member of the executive management team and negotiated and closed on multiple rounds of private financing before taking the company public in early 2013. She served as the public listed company CFO until the company was acquired in late 2014. Prior to Liposcience, Lucy was at Glaxo, Inc. and GlaxoWellcome for 17 years and held several financial management positions including Vice President of Financial Planning and Analysis for Glaxo, Inc. and Vice President, Finance Director for Global R&D for GlaxoWellcome. She has an M.B.A. from Campbell University and B.S. degree in Finance from the Indiana University Kelley School of Business.

Mr. Tim J. Fischer joined LipoScience in 2010 as Vice President of Research and Development and assumed the role of Chief Operating Officer in January, 2012. Prior to joining LipoScience, he served as Vice President of Development for the women’s health and cancer business at Becton Dickinson & Company (BD) and as the Vice President of Product Development for TriPath Oncology prior to the acquisition of TriPath by BD. Mr. Fischer has been in the IVD industry for the past 25 years in the fields of hematology, oncology and pathology, with extensive experience in the design, development and commercialization of over 90 products. He is a recognized leader in the IVD field with over 35 patents and numerous publications. Mr. Fischer has a Bachelor of Science degree in Biology from Indiana University.